Moreover, we also constructed CAR targeting CD7 and CD4, which were expressed on T-ALL cell lines, and CD19, CD30, and Mesothelin (MSLN), which had no expression on T-ALL cell lines. This evidence concerns the gene CD19 and acute lymphoblastic leukemia.